Close Menu

NEW YORK (GenomeWeb) – A set of circulating microRNAs appears to be able to distinguish patients with very high-risk prostate cancer, according to a team of researchers from Northwestern University.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.